Evidence map›Paper›PMID 39369107›Full record

ReviewAbdominal radiology (New York)2025

Artificial intelligence for detection and characterization of focal hepatic lesions: a review.

Julia Arribas Anta, Juan Moreno-Vedia, Javier García López, Miguel Angel Rios-Vives, Josep Munuera, Júlia Rodríguez-Comas

Abstract readReview
PubMed Publisher
In one paragraph

Review in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Julia Arribas AntaDepartment of Gastroenterology, University Hospital, 12 Octubre, Madrid, Spain.
Juan Moreno-VediaScientific and Technical Department, Sycai Technologies S.L., Barcelona, Spain.
Javier García LópezScientific and Technical Department, Sycai Technologies S.L., Barcelona, Spain.
Miguel Angel Rios-VivesDiagnostic Imaging Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Josep MunueraDiagnostic Imaging Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Júlia Rodríguez-ComasScientific and Technical Department, Sycai Technologies S.L., Barcelona, Spain. j.rodriguez@sycaitechnologies.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Focal liver lesions (FLL) are common incidental findings in abdominal imaging. While the majority of FLLs are benign and asymptomatic, some can be malignant or pre-malignant, and need accurate detection and classification. Current imaging techniques, such as computed tomography (CT) and magnetic resonance imaging (MRI), play a crucial role in assessing these lesions. Artificial intelligence (AI), particularly deep learning (DL), offers potential solutions by analyzing large data to identify patterns and extract clinical features that aid in the early detection and classification of FLLs. This manuscript reviews the diagnostic capacity of AI-based algorithms in processing CT and MRIs to detect benign and malignant FLLs, with an emphasis in the characterization and classification of these lesions and focusing on differentiating benign from pre-malignant and potentially malignant lesions. A comprehensive literature search from January 2010 to April 2024 identified 45 relevant studies. The majority of AI systems employed convolutional neural networks (CNNs), with expert radiologists providing reference standards through manual lesion delineation, and histology as the gold standard. The studies reviewed indicate that AI-based algorithms demonstrate high accuracy, sensitivity, specificity, and AUCs in detecting and characterizing FLLs. These algorithms excel in differentiating between benign and malignant lesions, optimizing diagnostic protocols, and reducing the needs of invasive procedures. Future research should concentrate on the expansion of data sets, the improvement of model explainability, and the validation of AI tools across a range of clinical setting to ensure the applicability and reliability of such tools.

Indexed as

Artificial IntelligenceImage Interpretation, Computer-AssistedLiver DiseasesLiver NeoplasmsMagnetic Resonance ImagingTomography, X-Ray ComputedDeep LearningDiagnosis, DifferentialHumansArtificia intelligenceCharacterizationComputed tomography (CT)DetectionDiagnosisFocal liver lesionsMagentic resonance imaging (MRI)

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.